These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
7. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis respiratory infections: interactions between bacteria and host defence. Döring G Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367 [TBL] [Abstract][Full Text] [Related]
13. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells. Friedl P; König B; König W Immunology; 1992 May; 76(1):86-94. PubMed ID: 1321094 [TBL] [Abstract][Full Text] [Related]
14. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes. Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966 [TBL] [Abstract][Full Text] [Related]
15. Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells. Hill PJ; Scordo JM; Arcos J; Kirkby SE; Wewers MD; Wozniak DJ; Torrelles JB Sci Rep; 2017 Jul; 7(1):4761. PubMed ID: 28684799 [TBL] [Abstract][Full Text] [Related]
16. Different sensitivity of Pseudomonas aeruginosa exotoxin A and diphtheria toxin to enzymes from polymorphonuclear leukocytes. Döring G; Müller E Microb Pathog; 1989 Apr; 6(4):287-95. PubMed ID: 2502701 [TBL] [Abstract][Full Text] [Related]
17. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Döring G; Goldstein W; Röll A; Schiøtz PO; Høiby N; Botzenhart K Infect Immun; 1985 Sep; 49(3):557-62. PubMed ID: 3928491 [TBL] [Abstract][Full Text] [Related]
18. Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. Malhotra S; Hayes D; Wozniak DJ Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142499 [TBL] [Abstract][Full Text] [Related]
19. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. Meluleni GJ; Grout M; Evans DJ; Pier GB J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254 [TBL] [Abstract][Full Text] [Related]
20. The Microbial Endocrinology of Pseudomonas aeruginosa: Inflammatory and Immune Perspectives. Yong VFL; Soh MM; Jaggi TK; Mac Aogáin M; Chotirmall SH Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):329-339. PubMed ID: 29541797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]